Skip to main content
. Author manuscript; available in PMC: 2013 Aug 12.
Published in final edited form as: Drugs Aging. 2009;26(3):209–230. doi: 10.2165/00002512-200926030-00003

Table V.

Meta-analyses of antithrombotic therapies in patients with atrial fibrillation: pooled data from randomized trials (reproduced from Singer et al.,[82] with permission)

Treatment comparison RRR for ischaemic stroke (95% CI)
Adjusted-dose OAC vs no antithrombotic therapy[84] 68% (50, 79)
ASA vs no antithrombotic therapy[85] 21% (0, 38)
Adjusted-dose OAC vs ASA[83] 52% (37, 63)

ASA = aspirin (acetylsalicylic acid); OAC = oral anticoagulation; RRR = relative risk reduction.